Table of Contents
Journal of Allergy
Volume 2009, Article ID 378245, 6 pages
http://dx.doi.org/10.1155/2009/378245
Research Article

Exercise-Induced Asthma Symptoms and Nighttime Asthma: Are They Similar to AHR?

Department of Respiratory Medicine, Bispebjerg Hospital, University of Copenhagen, 2400 Copenhagen NV, Denmark

Received 2 March 2009; Revised 22 June 2009; Accepted 5 October 2009

Academic Editor: William E. Berger

Copyright © 2009 V. Backer and L. M. Rasmussen. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Bousquet, N. Khaltaev, A. A. Cruz et al., “Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen),” Allergy, vol. 63, supplement 86, pp. 8–160, 2008. View at Google Scholar
  2. C. Porsbjerg, L. Rasmussen, H. Nolte, and V. Backer, “Association of airway hyperresponsiveness with reduced quality of life in patients with moderate to severe asthma,” Annals of Allergy, Asthma and Immunology, vol. 98, no. 1, pp. 44–50, 2007. View at Google Scholar · View at Scopus
  3. S. D. Anderson, “How does exercise cause asthma attacks?” Current Opinion in Allergy and Clinical Immunology, vol. 6, no. 1, pp. 37–42, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. S. D. Anderson, C. Caillaud, and J. D. Brannan, “β2-agonists and exercise-induced asthma,” Clinical Reviews in Allergy and Immunology, vol. 31, no. 2-3, pp. 163–180, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. S. D. Anderson and P. Kippelen, “Exercise-induced bronchoconstriction: pathogenesis,” Current Allergy and Asthma Reports, vol. 5, no. 2, pp. 116–122, 2005. View at Google Scholar · View at Scopus
  6. S. D. Anderson, “Single-dose agents in the prevention of exercise-induced asthma: a descriptive review,” Treatments in Respiratory Medicine, vol. 3, no. 6, pp. 365–379, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. K. W. Rundell, S. D. Anderson, B. A. Spiering, and D. A. Judelson, “Field exercise vs laboratory eucapnic voluntary hyperventilation to identify airway hyperresponsiveness in elite cold weather athletes,” Chest, vol. 125, no. 3, pp. 909–915, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. K. D. Fitch, “The use of anti-asthmatic drugs. Do they affect sports performance?” Sports Medicine, vol. 3, no. 2, pp. 136–150, 1986. View at Google Scholar · View at Scopus
  9. R. H. Green, C. E. Brightling, S. McKenna et al., “Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness,” European Respiratory Journal, vol. 27, no. 6, pp. 1144–1151, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. E. O. Meltzer, G. Philip, S. F. Weinstein et al., “Montelukast effectively treats the nighttime impact of seasonal allergic rhinitis,” American Journal of Rhinology, vol. 19, no. 6, pp. 591–598, 2005. View at Google Scholar · View at Scopus
  11. J. D. Brannan, H. Koskela, and S. D. Anderson, “Monitoring asthma therapy using indirect bronchial provocation tests,” The Clinical Respiratory Journal, vol. 1, no. 1, pp. 3–15, 2007. View at Publisher · View at Google Scholar
  12. G. P. Currie, “Why SMART about second-line treatment when first-line treatment is being ignored?” Chest, vol. 130, no. 3, p. 929, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Nolte, S. Nepper-Christensen, and V. Backer, “Unawareness and undertreatment of asthma and allergic rhinitis in a general population,” Respiratory Medicine, vol. 100, no. 2, pp. 354–362, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. L. M. Rasmussen, K. Phanareth, H. Nolte, and V. Backer, “Internet-based monitoring of asthma: a long-term, randomized clinical study of 300 asthmatic subjects,” Journal of Allergy and Clinical Immunology, vol. 115, no. 6, pp. 1137–1142, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. “Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986,” American Review of Respiratory Disease, vol. 136, no. 1, pp. 225–244, 1987. View at Scopus
  16. J. Bousquet, “Global initiative for asthma (GINA) and its objectives,” Clinical and Experimental Allergy, vol. 30, supplement 1, pp. 2–5, 2000. View at Google Scholar · View at Scopus
  17. P. C. Schrader, P. H. Quanjer, B. C. van Zomeren, E. G. de Groodt, A. M. Wever, and M. E. Wise, “Selection of variables from maximum expiratory flow-volume curves,” Bulletin Européen de Physiopathologie Respiratoire, vol. 19, no. 1, pp. 43–49, 1983. View at Google Scholar · View at Scopus
  18. K. Yan, C. Salome, and A. J. Woolcock, “Rapid method for measurement of bronchial responsiveness,” Thorax, vol. 38, no. 10, pp. 760–765, 1983. View at Google Scholar · View at Scopus
  19. G. O'Connor, D. Sparrow, D. Taylor, M. Segal, and S. Weiss, “Analysis of dose-response curves to methacholine: an approach suitable for population studies,” American Review of Respiratory Disease, vol. 136, no. 6, pp. 1412–1417, 1987. View at Google Scholar · View at Scopus
  20. S. Dreborg, L. Belin, N. E. Eriksson et al., “Results of biological standardization with standardized allergen preparations,” Allergy, vol. 42, no. 2, pp. 109–116, 1987. View at Google Scholar · View at Scopus
  21. E. D. Bateman, S. S. Hurd, P. J. Barnes et al., “Global strategy for asthma management and prevention: GINA executive summary,” European Respiratory Journal, vol. 31, no. 1, pp. 143–178, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Holzer, S. D. Anderson, H. K. Chan, and J. Douglass, “Mannitol as a challenge test to identify exercise-induced bronchoconstriction in elite athletes,” American Journal of Respiratory and Critical Care Medicine, vol. 167, no. 4, pp. 534–537, 2003. View at Google Scholar · View at Scopus
  23. K. W. Rundell and J. B. Slee, “Exercise and other indirect challenges to demonstrate asthma or exercise-induced bronchoconstriction in athletes,” Journal of Allergy and Clinical Immunology, vol. 122, no. 2, pp. 238–246, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Lund, L. Pedersen, B. Larsson, and V. Backer, “Prevalence of asthma-like symptoms, asthma and its treatment in elite athletes,” Scandinavian Journal of Medicine and Science in Sports, vol. 19, no. 2, pp. 174–178, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. V. Backer and C. S. Ulrik, “Bronchial responsiveness to exercise in a random sample of 494 children and adolescents from Copenhagen,” Clinical and Experimental Allergy, vol. 22, no. 8, pp. 741–747, 1992. View at Google Scholar · View at Scopus
  26. V. Backer, A. Dirksen, N. Bach-Mortensen, K. K. Hansen, E. M. Laursen, and D. Wendelboe, “The distribution of bronchial responsiveness to histamine and exercise in 527 children and adolescents,” Journal of Allergy and Clinical Immunology, vol. 88, no. 1, pp. 68–76, 1991. View at Google Scholar · View at Scopus
  27. G. Stratelis, P. Jakobsson, S. Molstad, and O. Zetterstrom, “Early detection of COPD in primary care: screening by invitation of smokers aged 40 to 55 years,” British Journal of General Practice, vol. 54, no. 500, pp. 201–206, 2004. View at Google Scholar · View at Scopus
  28. C. S. Ulrik, M.-L. von Linstow, S. Nepper-Christensen, C. Porsbjerg, and V. Backer, “Chronic mucus hypersecretion: a marker of asthma in young adults?” Respiratory Medicine, vol. 99, no. 12, pp. 1576–1582, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. K. D. Fitch, M. Sue-Chu, S. D. Anderson et al., “Asthma and the elite athlete: summary of the International Olympic Committee's Consensus Conference, Lausanne, Switzerland, January 22–24, 2008,” Journal of Allergy and Clinical Immunology, vol. 122, no. 2, pp. 254–260, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. G. W. Chalmers, K. J. Macleod, S. A. Little, L. J. Thomson, C. P. McSharry, and N. C. Thomson, “Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma,” Thorax, vol. 57, no. 3, pp. 226–230, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. S. C. Lazarus, V. M. Chinchilli, N. J. Rollings et al., “Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 175, no. 8, pp. 783–790, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. C. J. Lovett, B. F. Whitehead, and P. G. Gibson, “Eosinophilic airway inflammation and the prognosis of childhood asthma,” Clinical and Experimental Allergy, vol. 37, no. 11, pp. 1594–1601, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Malerba, B. Ragnoli, A. Radaeli, and C. Tantucci, “Usefulness of exhaled nitric oxide and sputum eosinophils in the long-term control of eosinophilic asthma,” Chest, vol. 134, no. 4, pp. 733–739, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. P. G. Gibson, “What do non-eosinophilic asthma and airway remodelling tell us about persistent asthma?” Thorax, vol. 62, no. 12, pp. 1034–1036, 2007. View at Publisher · View at Google Scholar · View at Scopus